The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter

See How Ligand Pharmaceuticals Ranks Among Analysts' Top Picks With Strong Buyback Activity

By The Online Investor Staff, Monday, October 18, 1:16 PM ET

A study of analyst recommendations at the major brokerages shows that Ligand Pharmaceuticals Inc (NASDAQ:LGND) is the #15 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period. In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the list of stocks with strong buyback activity was ranked according to those averages.

Investors are often keenly interested in knowing which companies are buying back their own stock, because companies often will only make such a move if they feel their stock is undervalued. Ligand Pharmaceuticals Inc is a company with strong buyback activity that is also considered a compelling buy by analysts; a bullish investor could take this to mean that sharp analyst minds came to the same bullish conclusion as the company itself that the stock is a good value, and therefore the stock should do well in the future.

Analysts studying companies buying back their own stock will also factor into their analysis that future earnings will now be spread over a smaller share count, thereby increasing the per-share earnings the remaining shares will enjoy, versus what that same number would have been absent the stock buyback activity.

LGND operates in the Biotechnology sector, among companies like Thermo Fisher Scientific Inc (TMO) which is up about 1.3% today, and Moderna Inc (MRNA) trading up by about 3.1%. Below is a three month price history chart comparing the stock performance of LGND, versus TMO and MRNA.

LGND,TMO,MRNA Relative Performance Chart

LGND is currently trading up about 0.3% midday Monday.

Find the right mix of model portfolios today at

This Article's Word Cloud:   Activity   Analyst   Analysts   Below   Biotechnology   Fisher   Investor   Investors   LGND   Ligand   MRNA   Moderna   Monday   Online   Pharmaceuticals   Picks   about   activity   also   among   analyst   back   bullish   buyback   buying   companies   company   earnings   future   have   list   major   make   month   often   over   same   share   shares   stock   stocks   strong   that   their   those   trading   versus   which   will   with

See How Ligand Pharmaceuticals Ranks Among Analysts' Top Picks With Strong Buyback Activity | | Copyright © 1998 - 2021, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.